Latest Period
Q2 2026
Security Snapshot
AEON Biopharma, Inc. - Class A Common Stock (AEON) Institutional Ownership
CUSIP: 00791X209
13F Institutional Holders and Ownership History from Q1 2025 to Q2 2026
Institutions Reporting
22
Shares (Excl. Options)
12,802,787
Price
$0.72
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Class A Common Stock
- Symbol
- AEON on NYSE
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 12,802,787
- Total 13F value
- $9,215,671
- Portfolio coverage rank
- 0%
- Share change
- +9,961,368
- Value change
- +$7,156,699
- Number of holders
- 22
- Shares outstanding
- 50,000,000
- SEC-reported price per share
- $0.26
- Insider filing price
- $0.26
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- AEON - AEON Biopharma, Inc. - Class A Common Stock is tracked under CUSIP 00791X209.
- 22 institutions reported positions in Q2 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 24 to 22 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $2,800,888 to $9,215,671.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 22 institutions filings for Q2 2026.
Security key
00791X209
Latest holder period
Q2 2026
13F holders
22
13D/G owners
5
CIK / CUSIP context first
Open Q2 2026 holders
AEON full holder history
AEON Biopharma, Inc. SEC filings
AEON Biopharma, Inc. company facts
AEON Biopharma, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 00791X209:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
AEON
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Stonepine Capital Management, LLC | 9.9% | $5,006,155 | 6,892,682 | Stonepine Capital Management, LLC | 15 Jul 2026 | |||
| LYNCH TIMOTHY P | 13% | $1,690,000 | 6,500,000 | Timothy P. Lynch | 19 Aug 2026 | |||
| Chernett Jorey | 9.9% | $564,250 | 1,128,500 | Chernett Jorey | 27 May 2025 | |||
| Alta Partners LLC | 2.1% | -60% | $192,400 | -$259,078 | 249,870 | -57% | Alta Partners LLC | 30 Sep 2025 |
| Dauntless Investment Group, LLC | 9.7% | $44,372 | 108,224 | Dauntless Investment Group, LLC | 26 Feb 2025 |
As of 30 Jun 2026, 22 institutional investors reported holding 12,802,787 shares of AEON Biopharma, Inc. - Class A Common Stock (AEON). This represents 26% of the company’s total 50,000,000 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
26%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Dauntless Investment Group, LLC | 25% | 12,490,154 | +394% | 16% | $8,984,168 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.19% | 95,311 | +9.5% | 0% | $68,556 |
| VANGUARD CAPITAL MANAGEMENT LLC | 0.18% | 90,529 | 0% | 0% | $65,090 |
| Blue Owl Capital Holdings LP | 0.08% | 42,353 | 0% | 0% | $30,494 |
| Formidable Asset Management, LLC | 0.04% | 20,024 | 0% | 0% | $19,724 |
| StoneX Group Inc. | 0.04% | 18,953 | 0% | $14,942 | |
| VANGUARD FIDUCIARY TRUST CO | 0.03% | 13,713 | -6.7% | 0% | $9,860 |
| LPL Financial LLC | 0.02% | 11,507 | 0% | 0% | $8,277 |
| CITIGROUP INC | 0.01% | 7,315 | +886% | 0% | $5,262 |
| UBS Group AG | 0.01% | 5,062 | +21% | 0% | $3,640 |
| BlackRock, Inc. | 0.01% | 2,834 | 0% | 0% | $2,038 |
| Tower Research Capital LLC (TRC) | 0.01% | 2,567 | +446% | 0% | $1,846 |
| Steward Partners Investment Advisory, LLC | 0% | 1,100 | 0% | 0% | $791 |
| WOLFF WIESE MAGANA LLC | 0% | 567 | 0% | 0% | $408 |
| SBI Securities Co., Ltd. | 0% | 232 | +121% | 0% | $167 |
| DUPONT CAPITAL MANAGEMENT CORP | 0% | 170 | 0% | 0.01% | $122 |
| MORGAN STANLEY | 0% | 150 | 0% | 0% | $108 |
| GHP Investment Advisors, Inc. | 0% | 95 | 0% | 0% | $69 |
| WELLS FARGO & COMPANY/MN | 0% | 90 | 0% | 0% | $65 |
| BARCLAYS PLC | 0% | 59 | 0% | $42 | |
| Caitong International Asset Management Co., Ltd | 0% | 1 | 0% | 0% | $1 |
| DANSKE BANK A/S | 0% | 1 | 0% | 0% | $1 |
| XTX Topco Ltd | 0% | 0 | -100% | $0 | |
| MAI Capital Management | 0% | 0 | -100% | $0 | |
| JANE STREET GROUP, LLC | 0% | 0 | -100% | $0 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
6
Latest
Q2 2026
Rows shown
1-6 of 6
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 12,802,787 | $9,215,671 | +$7,156,699 | $0.72 | 22 |
| 2026 Q1 | 2,841,419 | $2,800,888 | +$384,975 | $0.99 | 24 |
| 2025 Q4 | 2,443,029 | $1,667,217 | +$712,814 | $1.10 | 22 |
| 2025 Q3 | 1,364,447 | $1,103,333 | +$78,032 | $0.81 | 21 |
| 2025 Q2 | 1,271,217 | $585,730 | -$147,232 | $0.76 | 18 |
| 2025 Q1 | 1,526,776 | $884,785 | +$884,785 | $0.58 | 15 |